As demonstrated here, intratumoral accumulation of CD103+ DC populations at the tumor site served as a platform for the adjuvanted WT1-specific peptide vaccine booster, leading to generation of WT1 tetramer+CD8+ TILs and increases in overall survival. This evidence concerns the gene CD8A and neoplasm.